Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy.

Trial Profile

Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2012

At a glance

  • Drugs Memantine (Primary)
  • Indications Epilepsy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Jun 2010 Planned initiation date changed from 1 Oct 2009 to 1 Jul 2010 as reported by ClinicalTrials.gov.
    • 04 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top